pharmaceuticals

Appeal of non-traditional financials

Changing demographics in developed nations, a growing demand for both digital and physical infrastructure, and renewed interest in good corporate behaviour are set to rule 2016 and beyond.

Still positive on prospects

Sector expected to grow over next decade

Geoffrey C. Hsu, partner of OrbiMed and manager of the BiotechGrowth trust, assesses the key drivers for the sector in 2016 and beyond.

Does not follow sector classifications

Vishal Bhatia, co-manager of the JOHCM UK Growth fund, explores the companies deploying available surpluses to invest in themselves

Manager increases positions on weakness

Henderson's Ben Lofthouse lifts the lid on the team's favourite plays.

Markets tumble again